Regulation of the E2F-associated phosphoprotein promoter by GC-box binding proteins

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 12, 2008, Pages 2845-2853

  Schwarzmayr, Ludwig ^a   Andorfer, Peter ^a   Novy, Michael ^a   Rotheneder, Hans ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chromatin immunoprecipitation; E2F associated phosphoprotein (EAPP); GC box binding protein; Promoter; Reporter gene assay

Indexed keywords

BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; GC BOX BINDING PROTEIN; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CHROMATIN; COMPETITION; COMPUTER MODEL; GEL MOBILITY SHIFT ASSAY; GENE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; ISOLATION PROCEDURE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION;

CARRIER PROTEINS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GENES, REPORTER; HUMANS; LUCIFERASES; OSTEOSARCOMA; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 51249116257     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.06.001     Document Type: Article

References (44)

1. Abdelrahim M., Smith III R., Burghardt R., and Safe S. Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer Res 64 (2004) 6740-6749
2. Adamson E.D., and Mercola D. Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival. Tumour Biol 23 (2002) 93-102
3. Ammanamanchi S., Freeman J.W., and Brattain M.G. Acetylated sp3 is a transcriptional activator. J Biol Chem 278 (2003) 35775-35780
4. Baker A., Saltik M., Lehrmann H., Killisch I., Mautner V., Lamm G., et al. Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery. Gene Ther 4 (1997) 773-782
5. Borja P.F., Collins N.K., Du P., Azizkhan-Clifford J., and Mudryj M. Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription. EMBO J 20 (2001) 5737-5747
6. Courey A.J., and Tjian R. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55 (1988) 887-898 ISSN: 0092-8674
7. Doetzlhofer A., Rotheneder H., Lagger G., Koranda M., Kurtev V., Brosch G., et al. Histone deacetylase 1 can repress transcription by binding to Sp1. Mol Cell Biol 19 (1999) 5504-5511
8. Dynan W.S., and Tjian R. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell 35 (1983) 79-87 ISSN: 0092-8674
9. Favaloro J., Treisman R., and Kamen R. Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping. Methods Enzymol 65 (1980) 718-749
10. Ge Y., Jensen T.L., Matherly L.H., and Taub J.W. Physical and functional interactions between USF and Sp1 proteins regulate human deoxycytidine kinase promoter activity. J Biol Chem 278 (2003) 49901-49910
11. Hagen G., Muller S., Beato M., and Suske G. Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J 13 (1994) 3843-3851
12. Haidweger E., Novy M., and Rotheneder H. Modulation of Sp1 activity by a cyclin A/CDK complex. J Mol Biol 306 (2001) 201-212
13. Huang R.P., Fan Y., Ni Z., Mercola D., and Adamson E.D. Reciprocal modulation between Sp1 and Egr-1. J Cell Biochem 66 (1997) 489-499
14. Johnson D.G., and Degregori J. Putting the oncogenic and tumor suppressive activities of E2F into context. Curr Mol Med 6 (2006) 731-738
15. Kadonaga J.T., Carner K.R., Masiarz F.R., and Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51 (1987) 1079-1090 ISSN: 0092-8674
16. Kanai M., Wei D., Li Q., Jia Z., Ajani J., Le X., et al. Loss of Kruppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progression. Clin Cancer Res 12 (2006) 6395-6402
17. Kang H.T., Ju J.W., Cho J.W., and Hwang E.S. Down-regulation of Sp1 activity through modulation of O-glycosylation by treatment with a low glucose mimetic 2-deoxyglucose. J Biol Chem 278 (2003) 51223-51231
18. Karlseder J., Rotheneder H., and Wintersberger E. Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol Cell Biol 16 (1996) 1659-1667
19. Ko J.L., Liu H.C., and Loh H.H. Role of an AP-2-like element in transcriptional regulation of mouse micro-opioid receptor gene. Brain Res Mol Brain Res 112 (2003) 153-162
20. Kudlow J.E. Post-translational modification by O-GlcNAc: another way to change protein function. J Cell Biochem 98 (2006) 1062-1075
21. Lacroix I., Lipcey C., Imbert J., and Kahn-Perles B. Sp1 transcriptional activity is up-regulated by phosphatase 2A in dividing T lymphocytes. J Biol Chem 277 (2002) 9598-9605
22. Lagger G., O'Carroll D., Rembold M., Khier H., Tischler J., Weitzer G., et al. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J 21 (2002) 2672-2681
23. Lin S.Y., Black A.R., Kostic D., Pajovic S., Hoover C.N., and Azizkhan J.C. Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Mol Cell Biol 16 (1996) 1668-1675
24. Majello B., De Luca P., and Lania L. Sp3 is a bifunctional transcription regulator with modular independent activation and repression domains. J Biol Chem 272 (1997) 4021-4026
25. Novy M., Pohn R., Andorfer P., Novy-Weiland T., Galos B., Schwarzmayr L., et al. EAPP, a novel E2F binding protein that modulates E2F-dependent transcription. Mol Biol Cell 16 (2005) 2181-2190
26. Pagano M., Draetta G., and Jansen Durr P. Association of cdk2 kinase with the transcription factor E2F during S phase. Science 255 (1992) 1144-1147
27. Pang R.T., Lee L.T., Ng S.S., Yung W.H., and Chow B.K. CpG methylation and transcription factors Sp1 and Sp3 regulate the expression of the human secretin receptor gene. Mol Endocrinol 18 (2004) 471-483
28. Philipsen S., and Suske G. A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res 27 (1999) 2991-3000
29. Rotheneder H., Geymayer S., and Haidweger E. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter. J Mol Biol 293 (1999) 1005-1015
30. Rotheneder H., Grabner M., and Wintersberger E. Presence of regulatory sequences within intron 2 of the mouse thymidine kinase gene. Nucleic Acids Res 19 (1991) 6805-6809
31. Rotheneder H., Schwarzmayr L., Andorfer P., and Sarr A. Transcription factors of the E2F family and DNA damage control. Dynam Cell Biol 1 1 (2007) 48-59 ISSN: 1749-0561
32. Safe S., and Abdelrahim M. Sp transcription factor family and its role in cancer. Eur J Cancer 41 (2005) 2438-2448
33. Sapetschnig A., Koch F., Rischitor G., Mennenga T., and Suske G. Complexity of translationally controlled transcription factor Sp3 isoform expression. J Biol Chem 279 (2004) 42095-42105
34. Sapetschnig A., Rischitor G., Braun H., Doll A., Schergaut M., Melchior F., et al. Transcription factor Sp3 is silenced through SUMO modification by PIAS1. EMBO J 21 (2002) 5206-5215
35. Shi Q., Le X., Abbruzzese J.L., Peng Z., Qian C.N., Tang H., et al. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res 61 (2001) 4143-4154
36. Srivastava S., Weitzmann M.N., Kimble R.B., Rizzo M., Zahner M., Milbrandt J., et al. Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1. J Clin Invest 102 (1998) 1850-1859
37. Thiel G., and Cibelli G. Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 193 (2002) 287-292
38. Valin A., and Gill G. Regulation of the dual-function transcription factor Sp3 by SUMO. Biochem Soc Trans 35 (2007) 1393-1396
39. Wang L., Wei D., Huang S., Peng Z., Le X., Wu T.T., et al. Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 9 (2003) 6371-6380
40. Wong W.K., Chen K., and Shih J.C. Decreased methylation and transcription repressor Sp3 up-regulated human monoamine oxidase (MAO) B expression during Caco-2 differentiation. J Biol Chem 278 (2003) 36227-36235
41. Yang C., Bolotin E., Jiang T., Sladek F.M., and Martinez E. Prevalence of the initiator over the TATA box in human and yeast genes and identification of DNA motifs enriched in human TATA-less core promoters. Gene 389 (2007) 52-65
42. Yu B., Datta P.K., and Bagchi S. Stability of the Sp3-DNA complex is promoter-specific: Sp3 efficiently competes with Sp1 for binding to promoters containing multiple Sp-sites. Nucleic Acids Res 31 (2003) 5368-5376
43. Zannetti A., Del Vecchio S., Carriero M.V., Fonti R., Franco P., Botti G., et al. Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma. Cancer Res 60 (2000) 1546-1551
44. Zhang X., and Liu Y. Suppression of HGF receptor gene expression by oxidative stress is mediated through the interplay between Sp1 and Egr-1. Am J Physiol Renal Physiol 284 (2003) F1216-1225